Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
16,095,177
-
Share change
-
+1,883,959
-
Total reported value
-
$4,618,861,961
-
Put/Call ratio
-
190%
-
Price per share
-
$289.46
-
Number of holders
-
460
-
Value change
-
+$577,362,254
-
Number of buys
-
226
-
Number of sells
-
176
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q3 2016
As of 30 Sep 2016,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
460 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,095,177 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, CITIGROUP INC, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, BNP PARIBAS ARBITRAGE, SA, JPMORGAN CHASE & CO, UBS Group AG, ALLIANCEBERNSTEIN L.P., Clal Insurance Enterprises Holdings Ltd, and SG Americas Securities, LLC.
This page lists
460
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.